
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
DNA repair targeted therapy: The past or future of cancer treatment?
Navnath S. Gavande, Pamela S. VanderVere-Carozza, Hilary D. Hinshaw, et al.
Pharmacology & Therapeutics (2016) Vol. 160, pp. 65-83
Open Access | Times Cited: 340
Navnath S. Gavande, Pamela S. VanderVere-Carozza, Hilary D. Hinshaw, et al.
Pharmacology & Therapeutics (2016) Vol. 160, pp. 65-83
Open Access | Times Cited: 340
Showing 1-25 of 340 citing articles:
Biomolecular Condensates and Cancer
Ann Boija, Isaac A. Klein, Richard A. Young
Cancer Cell (2021) Vol. 39, Iss. 2, pp. 174-192
Open Access | Times Cited: 242
Ann Boija, Isaac A. Klein, Richard A. Young
Cancer Cell (2021) Vol. 39, Iss. 2, pp. 174-192
Open Access | Times Cited: 242
Obesity, DNA Damage, and Development of Obesity-Related Diseases
Marta Włodarczyk, Grażyna Nowicka
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 196
Marta Włodarczyk, Grażyna Nowicka
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 196
Molecular mechanisms of tumor resistance to radiotherapy
Yu Wu, Yingqiu Song, Runze Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 194
Yu Wu, Yingqiu Song, Runze Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 194
Replication Catastrophe: When a Checkpoint Fails because of Exhaustion
Luis Toledo, Kai J. Neelsen, Jiří Lukáš
Molecular Cell (2017) Vol. 66, Iss. 6, pp. 735-749
Open Access | Times Cited: 193
Luis Toledo, Kai J. Neelsen, Jiří Lukáš
Molecular Cell (2017) Vol. 66, Iss. 6, pp. 735-749
Open Access | Times Cited: 193
DNA Damage, Repair, and Cancer Metabolism
Marc‐Olivier Turgeon, Nicholas J. S. Perry, George Poulogiannis
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 193
Marc‐Olivier Turgeon, Nicholas J. S. Perry, George Poulogiannis
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 193
ATM in DNA repair in cancer
Mei Hua Jin, Do‐Youn Oh
Pharmacology & Therapeutics (2019) Vol. 203, pp. 107391-107391
Closed Access | Times Cited: 183
Mei Hua Jin, Do‐Youn Oh
Pharmacology & Therapeutics (2019) Vol. 203, pp. 107391-107391
Closed Access | Times Cited: 183
Harnessing DNA Double-Strand Break Repair for Cancer Treatment
Anika Trenner, Alessandro A. Sartori
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 167
Anika Trenner, Alessandro A. Sartori
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 167
Drugging the Cancers Addicted to DNA Repair
Jac A. Nickoloff, Dennie V. Jones, Suk‐Hee Lee, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 11
Open Access | Times Cited: 149
Jac A. Nickoloff, Dennie V. Jones, Suk‐Hee Lee, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 11
Open Access | Times Cited: 149
Repair of 8-oxo-7,8-dihydroguanine in prokaryotic and eukaryotic cells: Properties and biological roles of the Fpg and OGG1 DNA N-glycosylases
Serge Boiteux, F Coste, B. Castaing
Free Radical Biology and Medicine (2016) Vol. 107, pp. 179-201
Closed Access | Times Cited: 141
Serge Boiteux, F Coste, B. Castaing
Free Radical Biology and Medicine (2016) Vol. 107, pp. 179-201
Closed Access | Times Cited: 141
Biomarkers of Response and Resistance to DNA Repair Targeted Therapies
Elizabeth H. Stover, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 23, pp. 5651-5660
Open Access | Times Cited: 132
Elizabeth H. Stover, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 23, pp. 5651-5660
Open Access | Times Cited: 132
Modulating DNA Repair Pathways to Improve Precision Genome Engineering
Katherine S. Pawelczak, Navnath S. Gavande, Pamela S. VanderVere-Carozza, et al.
ACS Chemical Biology (2017) Vol. 13, Iss. 2, pp. 389-396
Closed Access | Times Cited: 125
Katherine S. Pawelczak, Navnath S. Gavande, Pamela S. VanderVere-Carozza, et al.
ACS Chemical Biology (2017) Vol. 13, Iss. 2, pp. 389-396
Closed Access | Times Cited: 125
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
Bagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee, et al.
Clinical & Translational Oncology (2018) Vol. 21, Iss. 3, pp. 268-279
Closed Access | Times Cited: 122
Bagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee, et al.
Clinical & Translational Oncology (2018) Vol. 21, Iss. 3, pp. 268-279
Closed Access | Times Cited: 122
Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay
Yanxin Lu, Yang Liu, Chunzhang Yang
Journal of Visualized Experiments (2017), Iss. 128
Open Access | Times Cited: 114
Yanxin Lu, Yang Liu, Chunzhang Yang
Journal of Visualized Experiments (2017), Iss. 128
Open Access | Times Cited: 114
Exploiting DNA repair defects in colorectal cancer
Nicole M. Reilly, Luca Novara, Federica Di Nicolantonio, et al.
Molecular Oncology (2019) Vol. 13, Iss. 4, pp. 681-700
Open Access | Times Cited: 107
Nicole M. Reilly, Luca Novara, Federica Di Nicolantonio, et al.
Molecular Oncology (2019) Vol. 13, Iss. 4, pp. 681-700
Open Access | Times Cited: 107
Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting
J. Biau, Emmanuel Chautard, Pierre Verrelle, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 107
J. Biau, Emmanuel Chautard, Pierre Verrelle, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 107
Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition
Brittany Haynes, Junko Murai, Jung‐Min Lee
Cancer Treatment Reviews (2018) Vol. 71, pp. 1-7
Open Access | Times Cited: 105
Brittany Haynes, Junko Murai, Jung‐Min Lee
Cancer Treatment Reviews (2018) Vol. 71, pp. 1-7
Open Access | Times Cited: 105
Fanconi Anemia Signaling and Cancer
Manoj Nepal, Raymond Che, Jun Zhang, et al.
Trends in cancer (2017) Vol. 3, Iss. 12, pp. 840-856
Open Access | Times Cited: 97
Manoj Nepal, Raymond Che, Jun Zhang, et al.
Trends in cancer (2017) Vol. 3, Iss. 12, pp. 840-856
Open Access | Times Cited: 97
P-TEFb Activation by RBM7 Shapes a Pro-survival Transcriptional Response to Genotoxic Stress
А. Н. Бугай, Alexandre J.C. Quaresma, Caroline C. Friedel, et al.
Molecular Cell (2019) Vol. 74, Iss. 2, pp. 254-267.e10
Open Access | Times Cited: 88
А. Н. Бугай, Alexandre J.C. Quaresma, Caroline C. Friedel, et al.
Molecular Cell (2019) Vol. 74, Iss. 2, pp. 254-267.e10
Open Access | Times Cited: 88
Role of Rad51 and DNA repair in cancer: A molecular perspective
Erik Laurini, Domenico Marson, Alice Fermeglia, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107492-107492
Open Access | Times Cited: 88
Erik Laurini, Domenico Marson, Alice Fermeglia, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107492-107492
Open Access | Times Cited: 88
DNA Oxidation and Excision Repair Pathways
Tae-Hee Lee, Tae‐Hong Kang
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6092-6092
Open Access | Times Cited: 86
Tae-Hee Lee, Tae‐Hong Kang
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6092-6092
Open Access | Times Cited: 86
Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy
Lukáš Górecki, Martin Andrš, Martina Řezáčová, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107518-107518
Closed Access | Times Cited: 86
Lukáš Górecki, Martin Andrš, Martina Řezáčová, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107518-107518
Closed Access | Times Cited: 86
Unboxing the molecular modalities of mutagens in cancer
Smita Kumari, Sudhanshu Sharma, Dia Advani, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 41, pp. 62111-62159
Open Access | Times Cited: 73
Smita Kumari, Sudhanshu Sharma, Dia Advani, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 41, pp. 62111-62159
Open Access | Times Cited: 73
Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis
Hardeep Singh Tuli, Jagjit Kaur, Kanupriya Vashishth, et al.
Archives of Toxicology (2022) Vol. 97, Iss. 1, pp. 103-120
Closed Access | Times Cited: 57
Hardeep Singh Tuli, Jagjit Kaur, Kanupriya Vashishth, et al.
Archives of Toxicology (2022) Vol. 97, Iss. 1, pp. 103-120
Closed Access | Times Cited: 57
Mutational signatures are markers of drug sensitivity of cancer cells
Jurica Levatić, Marina Salvadores, Francisco Fuster‐Tormo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Jurica Levatić, Marina Salvadores, Francisco Fuster‐Tormo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Bi-PE: bi-directional priming improves CRISPR/Cas9 prime editing in mammalian cells
Rui Tao, Yanhong Wang, Yaoge Jiao, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 11, pp. 6423-6434
Open Access | Times Cited: 52
Rui Tao, Yanhong Wang, Yaoge Jiao, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 11, pp. 6423-6434
Open Access | Times Cited: 52